000			02084 a2200613 4500
005			20250516041841.0
264		0	_c20111027
008			201110s 0 0 eng d
022			_a1432-0584
024	7		_a10.1007/s00277-011-1268-2 _2doi
040			_aNLM _beng _cNLM
100	1		_aHuang, Yu-Chung
245	0	0	_aLow absolute lymphocyte count and addition of rituximab confer high risk for interstitial pneumonia in patients with diffuse large B-cell lymphoma. _h[electronic resource]
260			_bAnnals of hematology _cOct 2011
300			_a1145-51 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aAntibodies, Monoclonal, Murine-Derived _xadministration & dosage
650	0	4	_aAntineoplastic Agents _xadministration & dosage
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aChina _xepidemiology
650	0	4	_aCohort Studies
650	0	4	_aDisease Susceptibility _xchemically induced
650	0	4	_aDrug Monitoring
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aIncidence
650	0	4	_aLung Diseases, Interstitial _xcomplications
650	0	4	_aLymphocyte Count
650	0	4	_aLymphoma, Large B-Cell, Diffuse _xblood
650	0	4	_aLymphopenia _xetiology
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aRetrospective Studies
650	0	4	_aRisk Factors
650	0	4	_aRituximab
650	0	4	_aSurvival Analysis
700	1		_aLiu, Chia-Jen
700	1		_aLiu, Chun-Yu
700	1		_aPai, Jih-Tung
700	1		_aHong, Ying-Chung
700	1		_aTeng, Hao-Wei
700	1		_aHsiao, Liang-Tsai
700	1		_aChao, Ta-Chung
700	1		_aGau, Jyh-Pyng
700	1		_aLiu, Jin-Hwang
700	1		_aHsu, Hui-Chi
700	1		_aChiou, Tzeon-Jye
700	1		_aChen, Po-Min
700	1		_aYu, Yuan-Bin
700	1		_aTzeng, Cheng-Hwai
773	0		_tAnnals of hematology _gvol. 90 _gno. 10 _gp. 1145-51
856	4	0	_uhttps://doi.org/10.1007/s00277-011-1268-2 _zAvailable from publisher's website
999			_c20905690 _d20905690